Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 3
2006 1
2007 3
2008 12
2009 13
2010 10
2011 10
2012 11
2013 14
2014 9
2015 10
2016 4
2017 4
2018 2
2019 3
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 23300442

102 results
Results by year
Filters applied: . Clear all
Page 1
Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G.
Stanley DJ, Bartholomeeusen K, Crosby DC, Kim DY, Kwon E, Yen L, Cartozo NC, Li M, Jäger S, Mason-Herr J, Hayashi F, Yokoyama S, Krogan NJ, Harris RS, Peterlin BM, Gross JD. Stanley DJ, et al. PLoS Pathog. 2012 Dec;8(12):e1003085. doi: 10.1371/journal.ppat.1003085. Epub 2012 Dec 27. PLoS Pathog. 2012. PMID: 23300442 Free PMC article.
Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
Jäger S, Kim DY, Hultquist JF, Shindo K, LaRue RS, Kwon E, Li M, Anderson BD, Yen L, Stanley D, Mahon C, Kane J, Franks-Skiba K, Cimermancic P, Burlingame A, Sali A, Craik CS, Harris RS, Gross JD, Krogan NJ. Jäger S, et al. Nature. 2011 Dec 21;481(7381):371-5. doi: 10.1038/nature10693. Nature. 2011. PMID: 22190037 Free PMC article.
T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.
Zhang W, Du J, Evans SL, Yu Y, Yu XF. Zhang W, et al. Nature. 2011 Dec 21;481(7381):376-9. doi: 10.1038/nature10718. Nature. 2011. PMID: 22190036
Identification of an HIV-1 replication inhibitor which rescues host restriction factor APOBEC3G in Vif-APOBEC3G complex.
Zhang S, Zhong L, Chen B, Pan T, Zhang X, Liang L, Li Q, Zhang Z, Chen H, Zhou J, Luo H, Zhang H, Bai C. Zhang S, et al. Antiviral Res. 2015 Oct;122:20-7. doi: 10.1016/j.antiviral.2015.07.009. Epub 2015 Aug 1. Antiviral Res. 2015. PMID: 26241003
Characterization of MRFAP1 turnover and interactions downstream of the NEDD8 pathway.
Larance M, Kirkwood KJ, Xirodimas DP, Lundberg E, Uhlen M, Lamond AI. Larance M, et al. Mol Cell Proteomics. 2012 Mar;11(3):M111.014407. doi: 10.1074/mcp.M111.014407. Epub 2011 Oct 29. Mol Cell Proteomics. 2012. PMID: 22038470 Free PMC article.
ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.
Hüttenhain R, Xu J, Burton LA, Gordon DE, Hultquist JF, Johnson JR, Satkamp L, Hiatt J, Rhee DY, Baek K, Crosby DC, Frankel AD, Marson A, Harper JW, Alpi AF, Schulman BA, Gross JD, Krogan NJ. Hüttenhain R, et al. Cell Host Microbe. 2019 Jul 10;26(1):86-99.e7. doi: 10.1016/j.chom.2019.05.008. Epub 2019 Jun 25. Cell Host Microbe. 2019. PMID: 31253590 Free PMC article.
APOBEC3G is degraded by the proteasomal pathway in a Vif-dependent manner without being polyubiquitylated.
Dang Y, Siew LM, Zheng YH. Dang Y, et al. J Biol Chem. 2008 May 9;283(19):13124-31. doi: 10.1074/jbc.M708728200. Epub 2008 Mar 6. J Biol Chem. 2008. PMID: 18326044 Free PMC article.
Biochemical and cellular effects of inhibiting Nedd8 conjugation.
Leck YC, Choo YY, Tan CY, Smith PG, Hagen T. Leck YC, et al. Biochem Biophys Res Commun. 2010 Jul 30;398(3):588-93. doi: 10.1016/j.bbrc.2010.06.128. Epub 2010 Jul 13. Biochem Biophys Res Commun. 2010. PMID: 20603103
ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction.
Miyakawa K, Matsunaga S, Kanou K, Matsuzawa A, Morishita R, Kudoh A, Shindo K, Yokoyama M, Sato H, Kimura H, Tamura T, Yamamoto N, Ichijo H, Takaori-Kondo A, Ryo A. Miyakawa K, et al. Nat Commun. 2015 Apr 22;6:6945. doi: 10.1038/ncomms7945. Nat Commun. 2015. PMID: 25901786 Free PMC article.
The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation.
Donahue JP, Vetter ML, Mukhtar NA, D'Aquila RT. Donahue JP, et al. Virology. 2008 Jul 20;377(1):49-53. doi: 10.1016/j.virol.2008.04.017. Epub 2008 May 21. Virology. 2008. PMID: 18499212 Free PMC article.
102 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback